Welcome to
XVir^® Therapeutics - The YB-1 Company^®

XVir^® Therapeutics GmbH is a biopharmaceutical company,
which provides YB-1 dependent oncolytic adenoviruses for oncolytic immunotherapy based on selective lysis of tumor cells and concomitant systemic anti-cancer immune response.

Our website is under reconstruction.